# Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation

> **NCT04065880** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 46 (actual)

## Conditions studied

- Prolonged Air Leak
- Postoperative Air Leak

## Interventions

- **OTHER:** TachoSil®
- **OTHER:** Neoveil®

## Key facts

- **NCT ID:** NCT04065880
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-07-31
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2023-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04065880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04065880, "Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04065880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*